Found 11 matching trials
Validation of Rivaroxaban Assay for US Registration
N/AThe objective of the study is to demonstrate the performances of the STA® -...
Location
Lehigh Valley Health Nrwork
Precision Medicine Platform for Novel Oral Anticoagulants
N/AThe anticoagulants have been developed with new generation for FDA-approved...
Location
Kaohsiung Medical University Hospital
Anti-Xa Assay Correlation to the Efficacy and Safety of Enoxaparin in the Treatment of Pulmonary Embolism
N/AThe aim of the present study is to monitor anticoagulant therapy by anti-Xa...
Location
Multiple Locations
Utilizing Anti-Factor Xa as a Predictive Tool for Optimizing Outcome in Burn Patients' Management
NAThis study aims to compare the efficacy of anti-Xa based versus weight-base...
Location
Ain Shams University
Utilization of TEG to Monitor Rivaroxaban Activity
N/AThe invesigators seek to devise a strategy for the assessment of Rivaroxaba...
Location
University of Pittsburgh Medical Center, PUH, 200 Lothrop Street
Heparin Requirements in Patients Undergoing Atrial Fibrillation Ablation on Coumadin vs NOACs
N/ATo observe, using a prospectively designed study, the effect of type of ora...
Location
St Elizabeth Medical Center
DOAC Versus VKA in Patients With Non-high-risk APS : Prospective Cohort Study
N/AAntiphospholipid syndrome (APS) is a thrombotic disease requiring prolonged...
Location
Central Hospital, Nancy, France
The OAT Trail: The Obesity Anti-Coagulation Thromboprophylaxis Trial.
NABlood clots in the legs or lungs (called venous thromboembolism or VTE) are...
Location
St Vincent's University Hospital
Early Versus Late Resumption of Anticoagulation in Patients With Both High Thrombosis Risk and Major HEmoRrhage
PHASE3In patients with a high thromboembolic risk, withdrawing anticoagulant trea...
Location
CHU de Saint-Etienne
Apixaban Validation Study - Additional Study on Fresh Samples
N/AThe objective is to demonstrate the performances of STA® - Apixaban Calibra...
Location
Moses Cone Memorial Hospital